4//SEC Filing
BLUNDELL MARK 4
Accession 0000899243-22-012980
CIK 0001415684other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 7:19 PM ET
Size
12.6 KB
Accession
0000899243-22-012980
Insider Transaction Report
Form 4
MusclePharm CorpMSLP
Transactions
- Sale
Common Stock
2022-03-29−626,826→ 3,021,529 total
Enright Todd M.
10% Owner
Transactions
- Sale
Common Stock
2022-03-29−626,826→ 3,021,529 total
Mahoney Robert P
10% Owner
Transactions
- Sale
Common Stock
2022-03-29−626,826→ 3,021,529 total
Transactions
- Sale
Common Stock
2022-03-29−626,826→ 3,021,529 total
BLUNDELL MARK
10% Owner
Transactions
- Sale
Common Stock
2022-03-29−626,826→ 3,021,529 total
Feagan Donald
10% Owner
Transactions
- Sale
Common Stock
2022-03-29−626,826→ 3,021,529 total
Footnotes (2)
- [F1]On March 29, 2022 (the "Transaction Date"), the Reporting Persons transferred 626,826 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), in an off-market transaction (the "Transaction").
- [F2]For purposes of the Transaction, the value of the transferred shares of Common Stock was deemed to be $0.39 per share, the last reported sale price of the Issuer's Common Stock on the Transaction Date.
Documents
Issuer
MusclePharm Corp
CIK 0001415684
Entity typeother
Related Parties
1- filerCIK 0001008190
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 7:19 PM ET
- Size
- 12.6 KB